Inhibition of ABCG2/BCRP transporter by soy isoflavones genistein and daidzein: Effect on plasma and milk levels of danofloxacin in sheep

Veterinary Journal

Volumn 196, Issue 2, 2013, Pages 203-208

  Perez, Miriam ^a   Otero, Jon A ^a   Barrera, Borja ^a   Prieto, Julio G ^a   Merino, Gracia ^a   Alvarez, Ana I ^a  

^a UNIVERSITY OF LEÓN   (Spain)

Author keywords

ABCG2 BCRP; Danofloxacin; Milk; Sheep; Soy

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; DAIDZEIN; DANOFLOXACIN; GENISTEIN; ISOFLAVONE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG ELIMINATION; DRUG MILK LEVEL; DRUG TRANSPORT; EWE; FEMALE; FORAGE; IN VITRO STUDY; MDCK CELL; NONHUMAN; SHEEP; TIME TO MAXIMUM PLASMA CONCENTRATION;

ANIMAL FEED; ANIMALS; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE; DOGS; DRUG INTERACTIONS; FLUOROQUINOLONES; GENE EXPRESSION REGULATION; GENISTEIN; HALF-LIFE; HUMANS; ISOFLAVONES; MILK; SHEEP; SOYBEANS;

OVIS ARIES;

EID: 84878923202     PISSN: 10900233     EISSN: 15322971     Source Type: Journal    
DOI: 10.1016/j.tvjl.2012.09.012     Document Type: Article

References (32)

1. Aliabadi F.S., Landoni M.F., Lees P. Pharmacokinetics (PK), pharmacodynamics (PD), and PK-PD integration of danofloxacin in sheep biological fluids. Antimicrobial Agents and Chemotherapy 2003, 47:626-635.
2. Allen J.D., van Loevezijn A., Lakhai J.M., van der Valk M., van Tellingen O., Reid G., Schellens J.H., Koomen G.J., Schinkel A.H. Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C. Molecular Cancer Therapeutics 2002, 1:417-425.
3. Alvarez A.I., Vallejo F., Barrera B., Merino G., Prieto J.G., Tomas-Barberan F., Espin J.C. Bioavailability of the glucuronide and sulfate conjugates of genistein and daidzein in breast cancer resistance protein 1 knockout mice. Drug Metabolism and Disposition 2011, 39:2008-2012.
4. Ballent M., Lifschitz A., Virkel G., Sallovitz J., Mate L., Lanusse C. In vivo and ex vivo assessment of the interaction between ivermectin and danofloxacin in sheep. The Veterinary Journal 2012, 192:422-427.
5. Bolca S., Urpi-Sarda M., Blondeel P., Roche N., Vanhaecke L., Possemiers S., Al-Maharik N., Botting N., De Keukeleire D., Bracke M., Heyerick A., Manach C., Depypere H. Disposition of soy isoflavones in normal human breast tissue. The American Journal of Clinical Nutrition 2010, 91:976-984.
6. Broderick G.A. Effects of varying dietary protein and energy levels on the production of lactating dairy cows. Journal of Dairy Science 2003, 86:1370-1381.
7. Cohen-Zinder M., Seroussi E., Larkin D.M., Loor J.J., Everts-van der Wind A., Lee J.H., Drackley J.K., Band M.R., Hernandez A.G., Shani M., Lewin H.A., Weller J.I., Ron M. Identification of a missense mutation in the bovine ABCG2 gene with a major effect on the QTL on chromosome 6 affecting milk yield and composition in Holstein cattle. Genome Research 2005, 15:936-944.
8. EMEA, 2002. Committee for Veterinary Medicinal Products. Danofloxacin. Summary Report 6. EMEA/MRL/818/02-Final, January 2002.
9. Enokizono J., Kusuhara H., Sugiyama Y. Effect of breast cancer resistance protein (Bcrp/Abcg2) on the disposition of phytoestrogens. Molecular Pharmacology 2007, 72:967-975.
10. Escudero E., Carceles C.M., Fernandez-Varon E., Marin P., Benchaoui H. Pharmacokinetics of danofloxacin 18% in lactating sheep and goats. Journal of Veterinary Pharmacology and Therapeutics 2007, 30:572-577.
11. Farrier, D.S., 1997. PK Solutions (Version 2.0.2): A Noncompartmental Pharmacokinetic Data Analysis Program. Summit Research Services, Ashland, OH, USA.
12. Garcia M.A., Solans C., Aramayona J.J., Rueda S., Bregante M.A. Development of a method for the determination of danofloxacin in plasma by HPLC with fluorescence detection. Biomedical Chromatography 2000, 14:89-92.
13. Imai Y., Tsukahara S., Asada S., Sugimoto Y. Phytoestrogens/flavonoids reverse breast cancer resistance protein/ABCG2-mediated multidrug resistance. Cancer Research 2004, 64:4346-4352.
14. Jonker J.W., Smit J.W., Brinkhuis R.F., Maliepaard M., Beijnen J.H., Schellens J.H., Schinkel A.H. Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan. Journal of the National Cancer Institute 2000, 92:1651-1656.
15. Marazuela M.D., Moreno-Bondi M.C. Multiresidue determination of fluoroquinolones in milk by column liquid chromatography with fluorescence and ultraviolet absorbance detection. Journal of Chromatography A 2004, 1034:25-32.
16. McKellar Q., Gibson I., Monteiro A., Bregante M. Pharmacokinetics of enrofloxacin and danofloxacin in plasma, inflammatory exudate, and bronchial secretions of calves following subcutaneous administration. Antimicrobial Agents and Chemotherapy 1999, 43:1988-1992.
17. Mealey K.L. ABCG2 transporter: Therapeutic and physiologic implications in veterinary species. Journal of Veterinary Pharmacology and Therapeutics 2012, 35:105-112.
18. Merino G., Alvarez A.I., Pulido M.M., Molina A.J., Schinkel A.H., Prieto J.G. Breast cancer resistance protein (BCRP/ABCG2) transports fluoroquinolone antibiotics and affects their oral availability, pharmacokinetics, and milk secretion. Drug Metabolism and Disposition 2006, 34:690-695.
19. Merino G., Perez M., Real R., Egido E., Prieto J.G., Alvarez A.I. In vivo inhibition of BCRP/ABCG2 mediated transport of nitrofurantoin by the isoflavones genistein and daidzein: A comparative study in Bcrp1(-/-) mice. Pharmaceutical Research 2010, 27:2098-2105.
20. Mestorino N., Marchetti M.L., Turic E., Pesoa J., Errecalde J. Concentrations of danofloxacin 18% solution in plasma, milk and tissues after subcutaneous injection in dairy cows. Analytica Chimica Acta 2009, 637:33-39.
21. Perez M., Real R., Mendoza G., Merino G., Prieto J.G., Alvarez A.I. Milk secretion of nitrofurantoin, as a specific BCRP/ABCG2 substrate, in Assaf sheep: Modulation by isoflavones. Journal of Veterinary Pharmacology and Therapeutics 2009, 32:498-502.
22. Poutrel B., Stegemann M.R., Roy O., Pothier F., Tilt N., Payne-Johnson M. Evaluation of the efficacy of systemic danofloxacin in the treatment of induced acute Escherichia coli bovine mastitis. The Journal of Dairy Research 2008, 75:310-318.
23. Pulido M.M., Molina A.J., Merino G., Mendoza G., Prieto J.G., Alvarez A.I. Interaction of enrofloxacin with breast cancer resistance protein (BCRP/ABCG2): Influence of flavonoids and role in milk secretion in sheep. Journal of Veterinary Pharmacology and Therapeutics 2006, 29:279-287.
24. Real R., Egido E., Perez M., Gonzalez-Lobato L., Barrera B., Prieto J.G., Alvarez A.I., Merino G. Involvement of breast cancer resistance protein (BCRP/ABCG2) in the secretion of danofloxacin into milk: Interaction with ivermectin. Journal of Veterinary Pharmacology and Therapeutics 2011, 34:313-321.
25. Real R., González-Lobato L., Baro M.F., Valbuena S., de la Fuente A., Prieto J.G., Alvarez A.I., Marqués M.M., Merino G. Analysis of the effect of the bovine ABCG2 SNP Y581S on transcellular transport of veterinary drugs using new cell culture models. Journal of Animal Science 2011, 89:4325-4338.
26. Schrickx J.A., Fink-Gremmels J. Danofloxacin-mesylate is a substrate for ATP-dependent efflux transporters. British Journal of Pharmacology 2007, 150:463-469.
27. Schrickx J.A., Fink-Gremmels J. Implications of ABC transporters on the disposition of typical veterinary medicinal products. European Journal of Pharmacology 2008, 585:510-519.
28. Shem-Tov M., Ziv G., Glickman A., Saran A. Pharmacokinetics and penetration of danofloxacin from the blood into the milk of ewes. Veterinary Research 1997, 28:571-579.
29. Urpi-Sarda M., Morand C., Besson C., Kraft G., Viala D., Scalbert A., Besle J.M., Manach C. Tissue distribution of isoflavones in ewes after consumption of red clover silage. Archives of Biochemistry and Biophysics 2008, 476:205-210.
30. Wang S.W., Chen Y., Joseph T., Hu M. Variable isoflavone content of red clover products affects intestinal disposition of biochanin A, formononetin, genistein, and daidzein. Journal of Alternative and Complementary Medicine 2008, 14:287-297.
31. Zhang S., Yang X., Morris M.E. Combined effects of multiple flavonoids on breast cancer resistance protein (ABCG2)-mediated transport. Pharmaceutical Research 2004, 21:1263-1273.
32. Zhang L., Zuo Z., Lin G. Intestinal and hepatic glucuronidation of flavonoids. Molecular Pharmaceutics 2007, 4:833-845.